1. Home
  2. RGLS vs XHG Comparison

RGLS vs XHG Comparison

Compare RGLS & XHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGLS
  • XHG
  • Stock Information
  • Founded
  • RGLS 2007
  • XHG 2012
  • Country
  • RGLS United States
  • XHG China
  • Employees
  • RGLS N/A
  • XHG N/A
  • Industry
  • RGLS Biotechnology: Pharmaceutical Preparations
  • XHG
  • Sector
  • RGLS Health Care
  • XHG
  • Exchange
  • RGLS Nasdaq
  • XHG NYSE
  • Market Cap
  • RGLS 102.8M
  • XHG 84.5M
  • IPO Year
  • RGLS 2012
  • XHG 2019
  • Fundamental
  • Price
  • RGLS $1.62
  • XHG $0.62
  • Analyst Decision
  • RGLS Strong Buy
  • XHG
  • Analyst Count
  • RGLS 6
  • XHG 0
  • Target Price
  • RGLS $10.33
  • XHG N/A
  • AVG Volume (30 Days)
  • RGLS 288.8K
  • XHG 38.2K
  • Earning Date
  • RGLS 08-08-2024
  • XHG 09-27-2024
  • Dividend Yield
  • RGLS N/A
  • XHG N/A
  • EPS Growth
  • RGLS N/A
  • XHG N/A
  • EPS
  • RGLS N/A
  • XHG 10.52
  • Revenue
  • RGLS N/A
  • XHG $10,628,627.00
  • Revenue This Year
  • RGLS N/A
  • XHG N/A
  • Revenue Next Year
  • RGLS N/A
  • XHG N/A
  • P/E Ratio
  • RGLS N/A
  • XHG $1.40
  • Revenue Growth
  • RGLS N/A
  • XHG N/A
  • 52 Week Low
  • RGLS $1.08
  • XHG $0.37
  • 52 Week High
  • RGLS $3.79
  • XHG $16.28
  • Technical
  • Relative Strength Index (RSI)
  • RGLS 49.97
  • XHG 26.88
  • Support Level
  • RGLS $1.47
  • XHG $0.62
  • Resistance Level
  • RGLS $1.72
  • XHG $0.75
  • Average True Range (ATR)
  • RGLS 0.12
  • XHG 0.08
  • MACD
  • RGLS 0.00
  • XHG -0.01
  • Stochastic Oscillator
  • RGLS 48.00
  • XHG 0.00

About RGLS Regulus Therapeutics Inc.

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)

XChange Tec Inc formerly FLJ Group Ltd is engaged in providing an apartment rental platform in China. The company leases apartments from landlords and transforms these apartments, into standardized furnished rooms to lease to people seeking residence in cities. It cooperates with third parties, including professional home service providers, e-commerce companies and other service providers to facilitate value-added services for its tenants.

Share on Social Networks: